|
Market Closed -
Other stock markets
|
After hours 00:55:18 | |||
| 298.76 USD | -4.49% |
|
304.86 | +2.04% |
| 07-09 | Raymond James Adjusts Price Target on Alnylam Pharmaceuticals to $468 From $420, Maintains Outperform Rating | MT |
| 07-09 | AstraZeneca's Wainua fails key heart disease trial, shares tumble | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 39.89B | |||||
| 1,060B | |||||
| 619B | |||||
| 438B | |||||
| 333B | |||||
| 282B |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition